Skip to main content
SpringerLink
Log in

Assessing the safety of daily vaginal estriol succinate

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pfeiler G, Glatz C, Konigsberg R, Geisendorfer T, Fink-Retter A, Kubista E, Singer CF, Seifert M.Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients. Climacteric: 13 Jan 2011. Available from: URL: http://dx.doi.org/10.3109/13697137.2010.529967

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assessing the safety of daily vaginal estriol succinate. React. Wkly. 1339, 2 (2011). https://doi.org/10.2165/00128415-201113390-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113390-00004

Keywords

Search

Navigation